Compare Kaltura Inc (KLTR) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kaltura Inc vs TransMedics Group Inc — how do they compare? Kaltura Inc trades at $1.35 (market cap $208.27M), while TransMedics Group Inc trades at $73.5 (market cap $2.54B). The key difference: TransMedics Group Inc is far larger — about 12.2× Kaltura Inc's market cap, and Kaltura Inc is trading nearer its 52-week high, TransMedics Group Inc nearer its low. Which is the better fit depends on your goals.
| KLTR | TMDX | |
|---|---|---|
Market Cap | $208.27M | $2.54B |
Sector | Technology | Technology |
52-Week High | $1.97 | $150.42 |
52-Week Low | $1.08 | $61.99 |
Enterprise Value | $190.99M | $2.94B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Kaltura (KLTR) trades at $1.43, up 2.88% on the day, with a bullish technical signal. The company shows improving fundamentals, with revenue stabilizing around $180M and net losses narrowing significantly from -$68M in 2022 to -$12M in 2025. Recent quarters have consistently beaten EPS expectations, and the company has garnered multiple industry awards, highlighting its leadership in agentic digital experience platforms.
The outlook is cautiously optimistic, with a path to profitability emerging, but risks remain from high debt levels and negative ROE. Analyst sentiment is mixed but leans positive, with 44% recommending Buy. The stock's valuation appears stretched on a P/B basis, requiring sustained execution for further upside.
TransMedics (TMDX) is trading at $73.47, down 0.69% on the day, amid a mixed technical and fundamental backdrop. The stock shows neutral technical signals with support near $72 and resistance at $75, while fundamentals are strong with a trailing P/E of 16.81 and robust profitability metrics like a 27.04% net income margin. Recent earnings saw a Q1 2026 miss but beats in prior quarters, and the company is expanding in Europe through strategic investments.
The outlook is cautiously optimistic with a consensus price target of $108.71 implying significant upside, supported by 75% analyst buy ratings. Key risks include margin pressure from expansion costs and competitive threats, but the company's organ transplant logistics network offers a durable competitive advantage for long-term growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kaltura Inc
Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments: (i) Enterprise, Education, and Technology (EE&T)
Read more on KLTR →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
